Skip to section navigation
Skip to page content

Research Projects on Health and Care

Understanding the financial ecosystem surrounding the development of medicines
To enable governments to make more informed policy decisions that optimise value for their citizens, while at the same time appropriately reimbursing innovators, researchers explored the evidence base on how medicines R&D is financed and how this may evolve in the future.
23 Jun 2022
Exploring the opportunities and challenges of research engagement with China
An independent and evidence-based study into UK academics' research engagement with China explored how and why UK academics engage with China on joint research activities with the goal of better understanding how UK research organisations manage any resulting risks.
22 Jun 2022
The impact of respiratory syncytial virus on the NHS, society and economy in the UK
Researchers estimate the total economic impact of respiratory syncytial virus (RSV) to be around £80 million each year, based on a rapid evidence assessment to model the disease's wider societal and economic burden in the UK.
31 May 2022
Understanding the evidence on the impacts of COVID-19 on work-related musculoskeletal disorders
Changes to working practices and environments due to the COVID-19 pandemic may have affected exposure to known work-related musculoskeletal disorder (WRMSD) risk factors. Researchers aim to understand this changing world of work, the effect on WRMSDs and post-pandemic considerations for WRMSDs.
17 May 2022
New insights into the medical use of cannabis
Researchers are examining the latest developments and available evidence concerning the medical use of cannabis and cannabinoids for the European Monitoring Centre for Drugs and Drug Addiction.
17 May 2022
The impact of predictive genetic tests on the insurance industry
Researchers developed a framework for evaluating the potential effects of predictive genetic tests on the UK insurance industry. The framework provides a transparent approach for evaluating whether a specific condition for which a test is available could impact the insurance industry and understanding the key factors that influence this.
08 Apr 2022
The indirect economic and societal burden of seasonal influenza on the UK
In 2019, absenteeism and presenteeism cost the UK economy almost £92 billion because of ill-health, but the economic burden specific to seasonal influenza is not well understood. Researchers are exploring the indirect economic and societal burden of seasonal influenza, including its effects on the UK healthcare system.
29 Mar 2022
The socioeconomic impact of poor indoor climate on health and life satisfaction
Poor indoor climate can result in a higher risk of health and wellbeing disorders, especially in children, the elderly and those with existing health conditions. Exposure of Europeans to damp, mould, and insufficient daylight in residential buildings could cost €53 billion over the next 30 years.
22 Mar 2022
Diagnosis, treatment and management of central diabetes insipidus
RAND Europe was commissioned by Ferring Pharmaceuticals to look at care pathways for patients with CDI. The research focused on identifying the factors that influence the diagnosis, treatment and management of patients with CDI, as well as areas to consider that may improve the quality of care that patients receive, and patient outcomes.
07 Mar 2022
Perspectives on factors most affecting quality of life in Greater Cambridge
Results of a survey and interviews of community stakeholders in the Greater Cambridge area found the factors that most affect quality of life in the region include personal relationships, public transport, and a sense of community.
01 Mar 2022
Evaluating the progress and impacts of the COG-UK consortium
An evaluation of the COVID-19 Genomics UK (COG-UK) consortium finds that it has made a significant and valuable contribution to the UK's public health genomics landscape, but its legacy will depend on decision makers' abilities to maintain momentum, ensure adequate governance, and other factors.
15 Feb 2022
Understanding industry contributions to the fight against antimicrobial resistance
The AMR Industry Alliance brings together over 100 biotechnology, diagnostic, generics and research-based biopharmaceutical companies and trade associations in the fight against AMR. RAND Europe assessed the progress of AMRIA members in contributing to tackling AMR and found they are making a difference on diverse fronts.
01 Feb 2022
Assessing the landscape of longitudinal data collection related to gambling
Researchers assessed the feasibility for expanding longitudinal data collection on gambling in the UK. They provide six distinct options, each with their own strengths and drawbacks, for consideration by the charity Action Against Gambling Harms.
25 Jan 2022
The impact of vertical integration of health services
In several locations across England and Wales, NHS organisations responsible for managing acute hospitals have also taken over the running of primary care medical practices. Vertical integration is a valuable option to consider when GP practices look likely to fail due to recruitment and financial difficulties, but it is not an option that should be imposed from the top down.
12 Jan 2022
Evaluating collaborations between primary care general practices in the UK
Primary care networks can help GPs run a wider range of services for their patients and make changes that are needed in response to the COVID-19 pandemic. It will be important to have additional clarification and support around the role of primary care networks in the wider NHS in England.
05 Jan 2022
Smoke-free environments and the advertising of tobacco and related products
Although EU member states are generally compliant with national rules on smoke-free environments and tobacco-related advertising, some areas require closer scrutiny, including protecting children from the harms of smoking.
04 Jan 2022
Assessing EHR for infectious disease surveillance, prevention and control
Electronic health records (EHR) data could greatly help infectious disease surveillance, but their use varies across Europe. Researchers mapped EHR use to assess the feasibility of using EHR data for infectious disease surveillance.
10 Dec 2021
Assessing POCT for infectious disease surveillance, prevention and control
Researchers examined the availability of point-of-care testing (POCT) devices to diagnose 56 communicable diseases and related health issues under EU surveillance — not including COVID-19 — and mapped trends in the use of POCT in Europe.
02 Dec 2021
Making outcome-based payment a reality in the NHS: Phase 2
To prepare for the implementation of a pilot scheme to pay for cancer drugs based on achieved outcomes, researchers addressed issues identified in the first phase of research, such as the quality and completeness of real-world data on key patient outcomes.
23 Nov 2021
Understanding how rail construction affects mental health and wellbeing
Researchers are exploring how the UK's High-Speed Rail 2 development might affect people who live near the railway line. What they learn will contribute to the design and assessment of later phases of the HS2 scheme.
18 Nov 2021

Page 2 of 6
Previous
1
2
3
4
5
6
Next